title: Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes.
abstract: Peripheral insulin resistance and impaired insulin action are the primary characteristics of type 2 diabetes. The first observable defect in this major disorder occurs in muscle, where glucose disposal in response to insulin is impaired. We have developed a transgenic mouse with a dominant-negative insulin-like growth factor-I receptor (KR-IGF-IR) specifically targeted to the skeletal muscle. Expression of KR-IGF-IR resulted in the formation of hybrid receptors between the mutant and the endogenous IGF-I and insulin receptors, thereby abrogating the normal function of these receptors and leading to insulin resistance. Pancreatic beta-cell dysfunction developed at a relative early age, resulting in diabetes. These mice provide an excellent model to study the molecular mechanisms underlying the development of human type 2 diabetes.
authors.affiliation: Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland 20892, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Fernández
authors.forename: J K
authors.initials: JK
authors.lastname: Kim
authors.forename: S
authors.initials: S
authors.lastname: Yakar
authors.forename: J
authors.initials: J
authors.lastname: Dupont
authors.forename: C
authors.initials: C
authors.lastname: Hernandez-Sanchez
authors.forename: A L
authors.initials: AL
authors.lastname: Castle
authors.forename: J
authors.initials: J
authors.lastname: Filmore
authors.forename: G I
authors.initials: GI
authors.lastname: Shulman
authors.forename: D
authors.initials: D
authors.lastname: Le Roith
mesh_terms: D000375:Aging; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000235:genetics* / Q000503:physiopathology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000378:metabolism*; D015309:Glucose Clamp Technique; D006801:Humans; D006946:Hyperinsulinism; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology; D007333:Insulin Resistance / Q000235:genetics*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D016297:Mutagenesis, Site-Directed; D011236:Prediabetic State / Q000097:blood / Q000235:genetics / Q000503:physiopathology; D017526:Receptor, IGF Type 1 / Q000235:genetics / Q000502:physiology*; D011972:Receptor, Insulin / Q000235:genetics / Q000502:physiology*; D014280:Triglycerides / Q000097:blood / Q000378:metabolism
chemical_list: D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014280:Triglycerides; D017526:Receptor, IGF Type 1; D011972:Receptor, Insulin; D005947:Glucose